We recently reported an involvement of peripheral angiotensin II (ANG II) in the development of both the fever and the peripheral interleukin (IL)-1 production induced in rats by a systemic injection of lipopolysaccharide (LPS). The present study was performed to investigate whether brain ANG II contributes to the fever and IL-1 production in the rat brain induced by i.c.v. injection of LPS. LPS (0.2 and 2 g i.c.v.) induced dose-related fevers and increases in the brain (hypothalamus, hippocampus, and cerebellum) concentrations of IL-1. These effects were significantly inhibited by i.c.v. administration of either an angiotensin-converting-enzyme (ACE) inhibitor or an angiotensin type 1 (AT 1 ) receptor antagonist. By contrast, the ACE inhibitor had no effect on the IL-1 (i.c.v.)-induced fever, whereas the AT 1 receptor antagonist enhanced (rather than reduced) it. The AT 1 receptor antagonist had no effect on the brain levels of prostaglandin E 2 in rats given an i.c.v. injection of IL-1. These results suggest that in rats, brain ANG II and AT 1 receptors are involved in the LPS-induced production of brain IL-1, thus contributing to the fever induced by the presence of LPS within the brain.Angiotensin II (ANG II), a bioactive peptide well known to play an important role in blood pressure and body fluid regulation, seems to participate in inflammatory responses, too. For example, an angiotensin-convertingenzyme (ACE) inhibitor has been shown to have an antiinflammatory effect (Godsel et al., 2003). Furthermore, ANG II and ANG II type 1 (AT 1 ) receptors are involved in cardiovascular inflammation, such as monocyte infiltration (Usui et al., 2000). Recently, we reported results suggesting that ANG II is involved in the development of the fever (an inflammation-related response) induced by i.v. injection of lipopolysaccharide (LPS, 2 g/kg) in euhydrated rats as well as in dehydrated rats (in which the secretion of ANG II is elevated) (Watanabe et al., 2000). In fact, the LPS-induced fever seen in that study was significantly attenuated by an ACE inhibitor, injected i.v. Because, as the first step in fever induction the pyrogenic/ proinflammatory cytokine interleukin (IL)-1 is released from macrophages after their stimulation by LPS (Kluger, 1991;Dinarello, 1999), we speculated that ANG II might contribute to the LPS-induced peripheral production of IL-1. Indeed, i.v. injection of LPS increases the liver concentration of IL-1 in dehydrated rats, and this effect can be significantly attenuated by an ACE inhibitor or by an AT 1 receptor antagonist, in each case given i.v. (Miyoshi et al., 2003). However, we found that an i.v. injection of LPS (2 g/kg) did not induce any detectable changes in the brain level of IL-1 (our unpublished observations). It seemed likely from these results that peripheral ANG II is involved in the development of the peripheral production of IL-1 (induced by LPS). The brain has its own renin-angiotensin system and its own AT 1 receptors that play important roles in blood press...